NHO Okayama Medical Center

Okayama 701-1192

3 studies enrolling now · 4 studies all time

What they study most

Acute Myocardial Infarction, Non-small Cell Lung Cancer, Pulmonary Arterial Hypertension

Studies at this site

• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer — Recruiting now
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed